Publications

Title

Author

Year

Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Hur, Y-G; CRAMPIN, AC; Chisambo, C; Kanyika, J; HOUBEN, R; Ndhlovu, R; MZEMBE, T; Lalor, MK; SAUL, J; BRANSON, K; Stanley, C; Ngwira, B; FRENCH, N; Ottenhoff, TH; DOCKRELL, HM; GORAK-STOLINSKA, P;

2013

Clinical and vaccine immunology, (2013).21 2 10.1128/CVI.00620-13.

Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

MacPherson, P; HOUBEN, RM G J; GLYNN, JR; CORBETT, EL; KRANZER, K;

2013

Bulletin of the World Health Organization, (2013).92 2 10.2471/BLT.13.124800.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel, J; Roper, MH; Herrera, C; Bonilla, C; Jave, O; Gianella, C; Sabogal, I; Huancaré, V; Leo, E; Tyas, A; Mendoza-Ticona, A; Caviedes, L; MOORE, DA J;

2013

Clinical microbiology and infection, (2013).20 6 10.1111/1469-0691.12401.

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

Hur, Y-G; GORAK-STOLINSKA, P; Ben-Smith, A; Lalor, MK; Chaguluka, S; Dacombe, R; Doherty, TM; Ottenhoff, TH; DOCKRELL, HM; CRAMPIN, AC;

2013

PloS one, (2013).8 11 10.1371/journal.pone.0079742.

Eligibility for isoniazid preventive therapy in South African gold mines.

LEWIS, JJ; FIELDING, KL; GRANT, AD; Chihota, VN; Popane, F; Luttig, M; Muller, D; Coetzee, L; CHURCHYARD, GJ;

2013

PloS one, (2013).8 11 10.1371/journal.pone.0081376.

Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity.

SUTHERLAND, JS; Loxton, AG; Haks, MC; Kassa, D; Ambrose, L; LEE, J-S; Ran, L; Van Baarle, D; Maertzdorf, J; Howe, R; Mayanja-Kizza, H; Boom, WH; Thiel, BA; CRAMPIN, AC; Hanekom, W; Ota, MO C; DOCKRELL, H; Walzl, G; Kaufmann, SH E; Ottenhoff, TH M; GCGH Biomarkers for TB consortium,;

2013

Clinical microbiology and infection, (2013).20 4 10.1111/1469-0691.12383.

Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.

GUPTA-WRIGHT, A; Wood, R; Bekker, L-G; Lawn, SD;

2013

Journal of acquired immune deficiency syndromes (1999), (2013).64 3 10.1097/QAI.0b013e3182a23e9a.

Factors Associated with In Vitro Immune Response to Mycobacterial and Tetanus Antigens Following BCG and Tetanus Immunisation in Infancy.

Lule, SA; Gyavira, N; Muhangi, L; Kizito, D; ELLIOTT, A; WEBB, E;

2013

AIDS research and human retroviruses, (2013).29 11

Respondent driven sampling: determinants of recruitment and a method to improve point estimation.

MCCREESH, N; Copas, A; SEELEY, J; Johnston, LG; Sonnenberg, P; HAYES, RJ; FROST, SD W; WHITE, RG;